Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
The HEALEY ALS Platform Trial achieves enrollment goal for its fourth regimen (pridopidine). The HEALEY ALS Platform Trial achieves enrollment goal for its fourth regimen (pridopidine). Completing enrollment for the fourth regimen in the Platform
Professor Michael Coleman and Professor Marc Freeman are incredible investigators in the field of axonal health and degeneration and their fundamental discoveries have facilitated drug discovery in this area.
The Pro-ACT team has demonstrated that they are forward-thinking innovators working endlessly to find the cure for ALS and we look forward to the progress that they will surely continue to make.
The International Symposium on ALS/MND is the largest medical and scientific conference specific to MND/ALS. Each year, the symposium brings together over 1,000 delegates to share and discuss the latest advances in research and clinical management of the disease.
This is a critical milestone, guiding the timeline for trial completion and result reporting, ultimately putting us on the path forward towards finding treatments for people with ALS.
Researchers discover new insights about tau proteins in people living with ALS. Researchers discover new insights about tau proteins in people living with ALS. Key Takeaways • Investigators found elevated levels of tau and a phosphorylated form of
Targeting tau with a new class of small molecules can reverse the ALS-induced changes in mitochondria’s shape and function.
The trial is the first phase 3 ALS trial with a global partnership beween TRICALS and NEALS.
An interview with the newest faculty member at the Healey Center for ALS.
The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH) awarded the 1st annual Gupta Family Endowed Prize for Innovation in ALS Care to Penn State Health Milton S. Hershey Medical Center ALS Clinic for pioneering decentralized multidisciplinary ALS care using digital health and targeted remote monitoring technologies.
Research at Massachusetts General Hospital integrates the full spectrum of "bench to bedside" discovery. Laboratory scientists work collaboratively with clinicians to make discoveries and turn them into treatments, diagnostics and devices that improve our quality of life.